NO20015810L - Substituerte fenylcykloheksankarboksylsyreamider som har en adenosinopptaksinhiberende effekt - Google Patents
Substituerte fenylcykloheksankarboksylsyreamider som har en adenosinopptaksinhiberende effektInfo
- Publication number
- NO20015810L NO20015810L NO20015810A NO20015810A NO20015810L NO 20015810 L NO20015810 L NO 20015810L NO 20015810 A NO20015810 A NO 20015810A NO 20015810 A NO20015810 A NO 20015810A NO 20015810 L NO20015810 L NO 20015810L
- Authority
- NO
- Norway
- Prior art keywords
- acid amides
- inhibitory effect
- adenosine uptake
- uptake inhibitory
- phenylcyclohexanecarboxylic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/14—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/18—Benzimidazoles; Hydrogenated benzimidazoles with aryl radicals directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Ophthalmology & Optometry (AREA)
- Anesthesiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19924818A DE19924818A1 (de) | 1999-05-29 | 1999-05-29 | Substituierte Phenylcyclohexancarbonsäureamide |
PCT/EP2000/004417 WO2000073275A1 (de) | 1999-05-29 | 2000-05-16 | Substituierte phenylcyclohexancarbonsäureamide mit adenosinaufnahme-hemmender wirkung |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20015810D0 NO20015810D0 (no) | 2001-11-28 |
NO20015810L true NO20015810L (no) | 2002-01-25 |
Family
ID=7909712
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20015810A NO20015810L (no) | 1999-05-29 | 2001-11-28 | Substituerte fenylcykloheksankarboksylsyreamider som har en adenosinopptaksinhiberende effekt |
Country Status (36)
Country | Link |
---|---|
US (2) | US6716849B1 (no) |
EP (1) | EP1185516B1 (no) |
JP (1) | JP2003500475A (no) |
KR (1) | KR20020003397A (no) |
CN (1) | CN1200932C (no) |
AR (1) | AR024100A1 (no) |
AT (1) | ATE238997T1 (no) |
AU (1) | AU765752B2 (no) |
BG (1) | BG106107A (no) |
BR (1) | BR0011061A (no) |
CA (1) | CA2375186A1 (no) |
CZ (1) | CZ20014288A3 (no) |
DE (2) | DE19924818A1 (no) |
DK (1) | DK1185516T3 (no) |
EE (1) | EE200100634A (no) |
ES (1) | ES2197870T3 (no) |
GT (1) | GT200000083A (no) |
HK (1) | HK1048810A1 (no) |
HN (1) | HN2000000072A (no) |
HR (1) | HRP20010955A2 (no) |
HU (1) | HUP0201350A3 (no) |
IL (1) | IL146392A0 (no) |
MA (1) | MA25414A1 (no) |
MX (1) | MXPA01012241A (no) |
MY (1) | MY122576A (no) |
NO (1) | NO20015810L (no) |
PE (1) | PE20010167A1 (no) |
PL (1) | PL352101A1 (no) |
PT (1) | PT1185516E (no) |
RU (1) | RU2246490C9 (no) |
SI (1) | SI1185516T1 (no) |
SK (1) | SK17052001A3 (no) |
SV (1) | SV2004000087A (no) |
UA (1) | UA73126C2 (no) |
WO (1) | WO2000073275A1 (no) |
ZA (1) | ZA200109263B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1834090B (zh) * | 2005-03-18 | 2011-06-29 | 中国科学院上海药物研究所 | 苯并咪唑类化合物、其制备方法以及用途 |
HUE025533T2 (en) * | 2008-06-16 | 2016-05-30 | Boehringer Ingelheim Int | A process for preparing an intermediate of dabigatran etexylate |
EP2858983B1 (en) | 2012-06-11 | 2018-04-18 | UCB Biopharma SPRL | Tnf-alpha modulating benzimidazoles |
CN113939525A (zh) * | 2018-11-25 | 2022-01-14 | 蓝谷制药有限责任公司 | 吉西他滨的口服活性前药 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2685918B1 (fr) * | 1992-01-08 | 1995-06-23 | Union Pharma Scient Appl | Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant. |
DE4221009A1 (de) * | 1992-06-26 | 1994-01-05 | Bayer Ag | Imidazolyl-substituierte Cyclohexanderivate |
EP0582164B1 (en) | 1992-07-31 | 1998-12-23 | Bristol-Myers Squibb Company | Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles |
DE4304455A1 (de) * | 1993-02-15 | 1994-08-18 | Bayer Ag | Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate |
DE4401893A1 (de) * | 1994-01-24 | 1995-07-27 | Bayer Ag | Substituierte Arylharnstoffe |
DE19503160A1 (de) | 1995-02-01 | 1996-08-08 | Bayer Ag | Verwendung von Phenylcyclohexylcarbonsäureamiden |
HRP960015B1 (en) | 1995-02-01 | 2000-12-31 | Bayer Ag | Substituted indole derivatives |
-
1999
- 1999-05-29 DE DE19924818A patent/DE19924818A1/de not_active Withdrawn
-
2000
- 2000-05-10 HN HN2000000072A patent/HN2000000072A/es unknown
- 2000-05-16 PT PT00925288T patent/PT1185516E/pt unknown
- 2000-05-16 ES ES00925288T patent/ES2197870T3/es not_active Expired - Lifetime
- 2000-05-16 CZ CZ20014288A patent/CZ20014288A3/cs unknown
- 2000-05-16 RU RU2001135715/04A patent/RU2246490C9/ru not_active IP Right Cessation
- 2000-05-16 CA CA002375186A patent/CA2375186A1/en not_active Abandoned
- 2000-05-16 PL PL00352101A patent/PL352101A1/xx not_active Application Discontinuation
- 2000-05-16 DK DK00925288T patent/DK1185516T3/da active
- 2000-05-16 EE EEP200100634A patent/EE200100634A/xx unknown
- 2000-05-16 SK SK1705-2001A patent/SK17052001A3/sk unknown
- 2000-05-16 US US09/980,243 patent/US6716849B1/en not_active Expired - Fee Related
- 2000-05-16 JP JP2000621341A patent/JP2003500475A/ja active Pending
- 2000-05-16 CN CNB008110492A patent/CN1200932C/zh not_active Expired - Fee Related
- 2000-05-16 DE DE50001982T patent/DE50001982D1/de not_active Expired - Fee Related
- 2000-05-16 EP EP00925288A patent/EP1185516B1/de not_active Expired - Lifetime
- 2000-05-16 SI SI200030147T patent/SI1185516T1/xx unknown
- 2000-05-16 BR BR0011061-2A patent/BR0011061A/pt not_active IP Right Cessation
- 2000-05-16 UA UA2001129201A patent/UA73126C2/uk unknown
- 2000-05-16 KR KR1020017015263A patent/KR20020003397A/ko active IP Right Grant
- 2000-05-16 HU HU0201350A patent/HUP0201350A3/hu unknown
- 2000-05-16 AU AU44055/00A patent/AU765752B2/en not_active Ceased
- 2000-05-16 MX MXPA01012241A patent/MXPA01012241A/es active IP Right Grant
- 2000-05-16 AT AT00925288T patent/ATE238997T1/de not_active IP Right Cessation
- 2000-05-16 WO PCT/EP2000/004417 patent/WO2000073275A1/de not_active Application Discontinuation
- 2000-05-16 IL IL14639200A patent/IL146392A0/xx unknown
- 2000-05-24 AR ARP000102549A patent/AR024100A1/es not_active Application Discontinuation
- 2000-05-26 MY MYPI20002352A patent/MY122576A/en unknown
- 2000-05-26 PE PE2000000506A patent/PE20010167A1/es not_active Application Discontinuation
- 2000-05-26 GT GT200000083A patent/GT200000083A/es unknown
- 2000-05-26 SV SV2000000087A patent/SV2004000087A/es unknown
-
2001
- 2001-11-09 ZA ZA200109263A patent/ZA200109263B/xx unknown
- 2001-11-13 BG BG106107A patent/BG106107A/bg unknown
- 2001-11-26 MA MA26427A patent/MA25414A1/fr unknown
- 2001-11-28 NO NO20015810A patent/NO20015810L/no not_active Application Discontinuation
- 2001-12-24 HR HR20010955A patent/HRP20010955A2/hr not_active Application Discontinuation
-
2003
- 2003-02-07 HK HK03100922.0A patent/HK1048810A1/zh unknown
-
2004
- 2004-03-18 US US10/805,548 patent/US20040186106A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20030153D0 (no) | Blandinger som inneholder terapeutisk aktive komponenter som har foröket löselighet | |
DE60319273D1 (de) | Entzunderungsdüse | |
DE602004006995D1 (de) | Elastisches befestigungssystem | |
NO20021367L (no) | Indolyl-3-glykosylsyrederivater som har terapeutisk verdifulle egenskaper | |
DE60326872D1 (de) | Lenksystem | |
NO20030100D0 (no) | Pleuromutilinderivater som har antibakteriell aktivitet | |
DE50210973D1 (de) | Meltblown-Anlage | |
DE602004020733D1 (de) | Aktives deckaufhängungssystem | |
NO20020430D0 (no) | Sonar system | |
FI20020430A0 (fi) | Hyllyjärjestelmä | |
NO20015810L (no) | Substituerte fenylcykloheksankarboksylsyreamider som har en adenosinopptaksinhiberende effekt | |
ITMI20020198A1 (it) | (per)aloeteri | |
DK1187812T3 (da) | Substituerede phenylcyclohexancarboxylsyreamider og deres anvendelse som adenosinoptagelses-inhibitorer | |
DE50304835D1 (de) | Servo-Lenkanlage | |
DE60304293D1 (de) | Sprühfeuchtwerk | |
FI20010209A (fi) | Laitteiston valvontajärjestelmä | |
DE60214822D1 (de) | Halterungssystem für eine Verlängerungsschnur | |
FI5620U1 (fi) | Kiinnityslaite laitapalkkeja varten | |
DE50300172D1 (de) | Stromschienensystem | |
DE60220721D1 (de) | Eduktor-mischersystem | |
DE10293796T1 (de) | Befestigungsstruktur für gekreuzte Leitungen | |
DE50301827D1 (de) | Verteilsystem | |
UA5003S (uk) | Стійка під штанги | |
ES1052519Y (es) | Armario distribuidor de corriente | |
NO20021489D0 (no) | Stabilisatorsystem for båter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |